DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "US Macular Edema Market and Competitive Landscape Highlights - 2016" drug pipelines to their offering.
US Macular Edema Market and Competitive Landscape Highlights - 2016, provides comprehensive insights into Macular Edema pipeline products, Macular Edema epidemiology, Macular Edema market valuations and forecast, Macular Edema products sales and competitive landscape in the US.
The research is classified into nine sections - Macular Edema overview including etiology, pathophysiology, and diagnosis, Macular Edema treatment options, Macular Edema pipeline products, Macular Edema market analysis comprising of Macular Edema epidemiology, key products marketed for Macular Edema, market valuations and forecast, products sales and market shares.
- Macular Edema Pipeline: Find out the products in clinical trials for the treatment of Macular Edema by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
- Macular Edema Epidemiology: Find out the number of patients diagnosed (prevalence) with Macular Edema in the US
- Macular Edema Products: Identify key products marketed and prescribed for Macular Edema in the US, including trade name, molecule name, and company
- Macular Edema Product Sales: Find out the sales revenues of Macular Edema products, both branded and generics, in the US
- Macular Edema Market Valuations: Find out the market size for Macular Edema products in 2015 in the US. Find out how the market advanced from 2010 and forecast to 2020
- Macular Edema Products Market Share: Find out the market shares for key Macular Edema products in the US
Key Topics Covered:
- Disease Overview
- Macular Edema Treatments
- Macular Edema Pipeline
- US Macular Edema Epidemiology
- Marketed Drugs for Macular Edema in US
- US Macular Edema Market Size
- US Macular Edema Products Sales
- US Macular Edema Market Competitive Landscape
- US Macular Edema Market Forecast
For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/cwd642/us_macular_edema